VWR, a global independent provider of products and services to laboratory and production customers, has acquired two companies, Reliable Biopharmaceutical and BioArra.

Reliable Biopharmaceutical is a manufacturer of active pharmaceutical ingredients (APIs) and high purity ingredients (HPIs) such as cGMP excipients and advanced intermediates for the biopharmaceutical industry. It enhances VWR’s growing custom chemical and biochemical manufacturing portfolio. Reliable Biopharma offers flexible, scalable and solution oriented production ranging from small batch clinical manufacturing to full-scale commercial production. Based in St. Louis, MO, and founded in 1968, Reliable Biopharmaceutical is a supplier for many pharmaceutical, biopharmaceutical, diagnostic and cosmetic companies.

BioArra is a producer of U.S. origin serum-based products for use in research and production and strengthens VWR’s support to cellular science customers. Founded in 2008 and headquartered in Eagleville, PA, BioArra produces semi-processed serum from various USDA approved supplier locations.

“BioArra and Reliable Biopharmaceutical greatly complement our previous acquisitions,” said Manuel Brocke-Benz, president and chief executive officer, VWR. “Aligned with our overall mergers and acquisitions strategy, these acquisitions continue to broaden our capabilities to provide value-added services and high quality products to our customers.”